Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-medication with sublingual fentanyl did not relieve pain associated with bone marrow aspiration and biopsy: a randomized feasibility trial.

European journal of pain (London, England)·2013
Same author

Von Willebrand disease in Finland.

Haemophilia : the official journal of the World Federation of Hemophilia·2013
Same author

Acute postinfectious glomerulonephritis associated with Campylobacter jejuni enteritis - a case report and review of the literature on C. jejuni's potential to trigger immunologically mediated renal disease.

Clinical nephrology·2010
Same author

Colonic involvement in a patient with chronic lymphocytic leukaemia.

Gastroenterology research and practice·2008
Same author

Comparative evaluation of oxidative and antioxidative capacity during high-flux hemodialysis using two different membranes.

Clinical nephrology·2006
Same author

Beta-2-glycoprotein I antibodies in patients with thrombosis.

Scandinavian journal of clinical and laboratory investigation·2003

Related Experiment Video

Updated: Jul 5, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

[Hepatitis C in Scandinavia]

F Ebeling1

  • 1Finlands Röda Kors Blodtjänst, Helsingfors.

Nordisk Medicin
|January 1, 1995
PubMed
Summary

Hepatitis C is uncommon in Nordic blood donors but prevalent in high-risk groups. Chronic liver disease, including cirrhosis, can develop, prompting ongoing research into treatments like alpha-interferon and ribavirin.

Area of Science:

  • Hepatology and Viral Gastroenterology
  • Public Health and Epidemiology

Context:

  • Nordic countries exhibit low overall Hepatitis C Virus (HCV) prevalence (0.05-0.30% in new blood donors).
  • HCV is disproportionately common in specific risk populations, including intravenous drug users and individuals with bleeding disorders.
  • Acute Hepatitis C is typically mild but frequently leads to chronic infection and potential liver damage.

Purpose:

  • To summarize the current epidemiological status of Hepatitis C in the Nordic region.
  • To highlight the long-term health consequences of Hepatitis C infection.
  • To report on the ongoing therapeutic research for Hepatitis C within the Nordic countries.

Summary:

  • Despite low general prevalence, Hepatitis C poses a significant risk to vulnerable groups in the Nordic region.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Experiment Videos

Last Updated: Jul 5, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

  • The virus often establishes a chronic carrier state, potentially progressing to asymptomatic liver inflammation and cirrhosis.
  • Research into alpha-interferon and oral ribavirin therapies is actively underway in the Nordic countries.

    • Impact:

    • Informs public health strategies for Hepatitis C prevention and management in low-prevalence areas.
    • Underscores the need for targeted screening and intervention in high-risk populations.
    • Contributes to the global understanding of Hepatitis C natural history and treatment efficacy.